First, the acquired resistance mechanism induced by the OPN/integrin αVβ3 pathway was confirmed only in EGFR-TKI-resistant PC9 cells, and our findings should be validated in various EGFR-TKI-resistant lung cancers. This evidence concerns the gene SPP1 and lung cancer.